Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons

2001, Enhancing transgender health care., Am J Public Health, 91, 869, 10.2105/AJPH.91.6.869

1999, From construction to context: gender through the eyes of the transgendered., SIECUS Rep, 28, 3

2014, Gender identification and sex reassignment surgery in the trans population: a survey study in France., Arch Sex Behav, 43, 1491, 10.1007/s10508-014-0382-3

2013, Female-to-male transmasculine adult health: a mixed-methods community-based needs assessment., J Am Psychiatr Nurses Assoc, 19, 293, 10.1177/1078390313500693

2010, Recommendations for revision of the DSM diagnoses of gender identity disorders: consensus statement of the World Professional Association for Transgender Health., Int J Transgend, 12, 115, 10.1080/15532739.2010.509215

2010, Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes., Clin Endocrinol (Oxf), 72, 214, 10.1111/cen.2010.72.issue-2

2017, Thrombotic issues in transgender medicine: a review., Am J Hematol, 92, 204, 10.1002/ajh.24593

2010, Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses., Clin Endocrinol (Oxf), 72, 1, 10.1111/(ISSN)1365-2265

2015, Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals., J Clin Transl Endocrinol, 2, 55, 10.1016/j.jcte.2015.02.003

2017, Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review., Ann Intern Med, 167, 256, 10.7326/M17-0577

et al, 2017, Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis., J Clin Endocrinol Metab, 102, 3914, 10.1210/jc.2017-01643

et al, 2016, Advancing methods for US transgender health research., Curr Opin Endocrinol Diabetes Obes, 23, 198, 10.1097/MED.0000000000000229

et al, 2016, A novel method for estimating transgender status using electronic medical records., Ann Epidemiol, 26, 198, 10.1016/j.annepidem.2016.01.004

et al, 2017, Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people., BMJ Open, 7, e018121, 10.1136/bmjopen-2017-018121

et al, 2017, Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline., J Clin Endocrinol Metab, 102, 3869, 10.1210/jc.2017-01658

2017, Sensitivity analysis in observational research: introducing the E-value., Ann Intern Med, 167, 268, 10.7326/M16-2607

et al, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial., JAMA, 288, 321, 10.1001/jama.288.3.321

1999, Hormone replacement therapy with estradiol and risk of venous thromboembolism—a population-based case-control study., Thromb Haemost, 82, 1218, 10.1055/s-0037-1614363

et al, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study., Circulation, 115, 840, 10.1161/CIRCULATIONAHA.106.642280

EStrogen and THromboEmbolism Risk Study Group, 2003, Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk., Lancet, 362, 428, 10.1016/S0140-6736(03)14066-4

et al, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study., Arterioscler Thromb Vasc Biol, 30, 340, 10.1161/ATVBAHA.109.196022

2013, The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy., J Thromb Haemost, 11, 124, 10.1111/jth.12060

2010, Hormone replacement therapy and the risk of venous thromboembolism: a population-based study., J Thromb Haemost, 8, 979, 10.1111/j.1538-7836.2010.03839.x

et al, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial., JAMA, 291, 1701, 10.1001/jama.291.14.1701

et al, 2000, Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study., Ann Intern Med, 132, 689, 10.7326/0003-4819-132-9-200005020-00002

2012, Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens., J Clin Endocrinol Metab, 97, 4422, 10.1210/jc.2012-2030

2014, Racial health disparities in a cohort of 5,135 transgender veterans., J Racial Ethn Health Disparities, 1, 257, 10.1007/s40615-014-0032-4

2016, Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the Veterans Health Administration: a case-control study., LGBT Health, 3, 122, 10.1089/lgbt.2015.0058

1997, Mortality and morbidity in transsexual subjects treated with cross-sex hormones., Clin Endocrinol (Oxf), 47, 337, 10.1046/j.1365-2265.1997.2601068.x

et al, 2013, Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study., Eur J Endocrinol, 169, 471, 10.1530/EJE-13-0493

1995, Survival Analysis: A Self-Learning Text